Evidence map›Paper›PMID 42056555›Full record

ReviewCommunications medicine2026

Challenges and strategies for delivering effective breast cancer care in conflict zones.

Nader Hirmas, Johannes Holtschmidt, Stephan Falk, Ernst Hanisch, Carsten Denkert, Jörg Heil, Thomas Decker, David Krug, Sibylle Loibl

Abstract readReview
In one paragraph

Review in Communications medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nader HirmasGerman Breast Group, c/o GBG Forschungs GmbH, Neu-Isenburg, Germany.ORCID http://orcid.org/0000-0002-3231-8246
Johannes HoltschmidtGerman Breast Group, c/o GBG Forschungs GmbH, Neu-Isenburg, Germany.
Stephan FalkCenter for Histology, Cytology and Molecular Diagnostics Trier, Trier, Germany.
Ernst HanischGoethe University Frankfurt, Frankfurt am Main, Germany.
Carsten DenkertInstitute of Pathology, Philipps-University Marburg and University Hospital Marburg (UKGM)-Universitätsklinikum Marburg, Marburg, Germany.ORCID http://orcid.org/0000-0002-2249-0982
Jörg HeilBrustzentrum Heidelberg an der Klinik St. Elisabeth, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-4684-9099
Thomas DeckerMVZ für Hämatologie und Onkologie Ravensburg GmbH, Ravensburg, Germany.
David KrugDepartment of Radiation Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.
Sibylle LoiblGerman Breast Group, c/o GBG Forschungs GmbH, Neu-Isenburg, Germany. sibylle.loibl@gbg.de.ORCID http://orcid.org/0000-0001-6488-4958

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer remains the most frequently diagnosed cancer among women worldwide, and its burden is particularly severe in regions affected by conflict and war. In these settings, oncology care is often disrupted by the destruction of healthcare infrastructure, displacement of populations, shortages of trained personnel, and limited access to diagnostics and treatment. This paper presents a multidisciplinary, practice-oriented, and resource-stratified framework for delivering breast cancer care in conflict zones, offering practical guidance for clinicians, healthcare workers, and humanitarian organizations. Drawing on literature, field experiences, and expert insight across oncology, pathology, radiology, surgery, radiation oncology, psycho-oncology, and public health, we outline key challenges and propose context-adapted strategies spanning early detection, diagnosis, treatment, and psychosocial support. Emphasis is also placed on multidisciplinary and collaborative efforts, policy and strong advocacy at local, national, and international levels, as well as ethical considerations in humanitarian settings.

Identifiers

PMID42056555
PMCPMC13128915

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.